Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    Optimizing HRRm Testing and Workflow Integration in mCSPC
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across Canada
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Optimizing Disease Management to Improve Alopecia Areata Quality of Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) Therapy
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Canada
    2026 Headache Medicine Fellowship - US
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Internal Medicine USA
    Advances in Migraine Management
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Real-World Evidence of SUL-DUR on Special Populations with CRAB Infection
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local Level
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom
    Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patients
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Spain
    Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Efforts to Improve Quality of Migraine Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Internal Medicine Japan
    Enhancing HCP Education in Adult Vaccination against Respiratory Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland
    Migraine and Women’s Health
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement, Research Internal Medicine USA
    Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare Professionals
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Prostate Cancer: Best Practices for Combining Targeted Therapies in mPC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Optimizing Adult Vaccination Ecosystem in India
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines India
    Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Spain
    Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    Enhancing HCP Education in Maternal Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Saudi Arabia
    Diagnosis and Treatment of Cancer Cachexia
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2026 Hemophilia Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi Arabia
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Saudi Arabia
    Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing Equity
    Release Date:
    Review Process: Expert Review Panel
    Education Inflammation & Immunology Australia
    Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in Türkiye
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Turkey
    Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in Türkiye
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Turkey
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions
    Release Date:
    Review Process:
    Improving the Clinical Management of Uncontrolled Acromegaly
    Release Date:
    Review Process:
    Antimicrobial Stewardship in the Asia-Pacific Region
    Release Date:
    Review Process:
    Lysosomal Storage Disorders Fellowship for Nurse Practitioners
    Release Date:
    Review Process:
    Hemophilia PUP Registry
    Release Date:
    Review Process:
    Quality Improvement Initiatives:Improving Screening and Diagnosis of Atrial Fibrillation and Optimizing Treatment and Management
    Release Date:
    Review Process:
    Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions
    Release Date:
    Review Process:
    Accelerating the Detection, Diagnosis and Initial Treatment of Psoriatic Arthritis
    Release Date:
    Review Process:
    Improving the Identification and Management of Patients with Atrial Fibrillation (AF) and venous thromboembolism (VTE)
    Release Date:
    Review Process:
    Medication Optimization in Primary Care
    Release Date:
    Review Process:
    Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
    Release Date:
    Review Process:
    Increasing Rates of BRCA Testing in Patients with Breast Cancer
    Release Date:
    Review Process:
    Providing Access to Learning Resources for Nurses in Africa
    Release Date:
    Review Process:
    Increasing Adult Pneumococcal Immunization Rates through AAFP State Chapters
    Release Date:
    Improving Vaccine Utilization and Preventive Health Maintenance in IBD
    Release Date:
    Review Process:
    Supporting Educational Programs for Radical Reform of Pain Treatment in Japan
    Release Date:
    Review Process:
    Improving Pediatric Immunization Care – Innovative Strategies to Improve Childhood Immunization Rates
    Release Date:
    Review Process:
    Rheumatology Nurse Practitioner and Physician Assistant Fellowship
    Release Date:
    Review Process:
    Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process:
    Improving Pneumococcal Immunization of Adults with Immunocompromising Conditions
    Release Date:
    Review Process:
    Efforts for Early Detection of Atrial Fibrillation and Prevention of Cardio Embolic Stroke
    Release Date:
    Review Process:
    Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
    Release Date:
    Review Process:
    Project CHANGE - Clinical practice oriented cHange solutions towards Active aNd healthy aGEing
    Release Date:
    Review Process:
    QI Initiaitives Focused on Undiagnosed Nonvalvular Atrial Fibrillation (NVAF)
    Release Date:
    Review Process:
    Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Review Process:
    Improving the Management of Patients with Uncontrolled Acromegaly (International Developed Markets)
    Release Date:
    Review Process:
    Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including Dialys
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Albania
    Integrated Approach to Breast Health Equity
    Release Date:
    Review Process:
    Patient Registries In Metastatic Breast Cancer
    Release Date:
    Review Process:
    Improving Patient Care in Tobacco Dependency
    Release Date:
    Review Process:
    Antimicrobial Stewardship in the Latin America Region
    Release Date:
    Review Process:
    Management of Atopic Dermatitis – International Developed Markets
    Release Date:
    Review Process:
    Improving Standard of Care for Chronic AD
    Release Date:
    Review Process:
    NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care
    Release Date:
    Review Process:
    Translating the Atopic Dermatitis (AD)
    Release Date:
    Review Process:
    UK Oncology Quality Improvement Grants
    Release Date:
    Review Process:
    Treatment Patterns of CDK 4/6 Inhibitor Utilization in HR+/HER2- Metastatic Breast Cancer
    Release Date:
    Review Process:
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process:
    Vaccines for All: Longevity Unleashed for Everyone (VALUE)
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines Japan
    Breast Cancer Competitive Research Grant Program for Africa, the Middle East, Asia and Latin America Regions
    Release Date:
    Review Process: Expert Review Panel
    Research Oncology All
    Bristol-Myers Squibb/Pfizer Alliance Announce Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Partner:

    Bristol-Myers Squibb

    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process:
    Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Local Level Educational Grants Program to Increase Awareness and Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Addressing Knowledge Gaps for the Appropriate Use of Biosimilars
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Acromegaly/Growth Hormone Excess Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA